Clinical trial
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
NCT00022412 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00022412 |
|---|---|
| Title | Doxercalciferol Before Surgery in Treating Localized Prostate Cancer |
| Official title | Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement, Procedure |
| Interventions | doxercalciferol, conventional surgery |
| Enrollment | 60 |
| Start date | Aug 1, 2001 |
| Primary completion | Feb 1, 2006 |
| Completion | Aug 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 13, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: